Shenge formula reduces hepatic lipid deposition in patients with metabolic-dysfunction-associated fatty liver disease (MAFLD): a randomized, placebo-controlled, double-blinded clinical trial

Authors
Category Primary study
Conference34th Annual Meeting of the Asian Pacific Association for the Study of the Liver, APASL 2025
Year 2025
This article has no abstract
Epistemonikos ID: f373741938afe5a7b71d7425d38c6741ad7f93ff
First added on: Jan 10, 2026